PROSTATE CANCER RECURRENT
Clinical trials for PROSTATE CANCER RECURRENT explained in plain language.
Never miss a new study
Get alerted when new PROSTATE CANCER RECURRENT trials appear
Sign up with your email to follow new studies for PROSTATE CANCER RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise in slowing advanced prostate cancer
Disease control CompletedThis study tested whether adding a new immunotherapy drug, lorigerlimab, to standard chemotherapy (docetaxel) could help men with a hard-to-treat type of advanced prostate cancer live longer without their disease getting worse. About 154 men took part, receiving either the drug c…
Matched conditions: PROSTATE CANCER RECURRENT
Phase: PHASE2 • Sponsor: MacroGenics • Aim: Disease control
Last updated May 17, 2026 00:53 UTC
-
New imaging methods may spot recurrent prostate cancer more accurately
Diagnosis CompletedThis study tested two imaging techniques—Histoscanning™ and multiparametric MRI—to see how well they can find prostate cancer that comes back after radiation therapy. Thirty men with signs of recurrence had both scans, followed by targeted and random biopsies to check accuracy. T…
Matched conditions: PROSTATE CANCER RECURRENT
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Diagnosis
Last updated May 17, 2026 01:02 UTC